series-a
Stage
1
Investors
About
Mapi Pharma Ltd. is a clinical-stage pharmaceutical company developing added-value generic drugs, including complex active pharmaceutical ingredients, formulations, and life cycle management products targeting large markets. Its lead product is an extended-release version of Teva's Copaxone, used to treat Multiple Sclerosis.
Explore Mapi Pharma Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.